InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Wilkins H Jeffrey, Directeur Médical. Officer active across 3 companies, notably Cerecor Inc.. Cumulatively, 4 filings have been published. Total volume traded: €21k. The latest transaction was filed on 10 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€8,8576,371 shares@ €1.3902100.0% of flow
Common Stock
SEC:0001879785-21-000041·
Ideal exit: 6 Sept 2022 (T+270)
€8,8576,371 shares@ €1.39020.0026% mcap50.0% of flow
Common Stock
SEC:0001879785-21-000041:0·
Ideal exit: 6 Sept 2022 (T+270)
€1,708912 shares@ €1.8731100.0% of flow
Common Stock
SEC:0001192482-21-000498·
Ideal exit: 7 Mar 2022 (T+270)
€1,708912 shares@ €1.8731100.0% of flow
Common Stock
SEC:0001192482-21-000498:0·
Ideal exit: 7 Mar 2022 (T+270)
4 of 4 declarations
About Wilkins H Jeffrey
H. Jeffrey Wilkins is the Chief Medical Officer at Cerecor Inc. and Avalo Therapeutics, Inc. He is responsible for the medical direction and clinical strategy of these companies. H. Jeffrey Wilkins leverages his expertise to ensure that medical products and services meet quality and safety standards. His role is essential in supporting innovation and research in the healthcare field.
